PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Journals
More Content
PLOS BLOGS Speaking of Medicine and Health
Browse all PLOS Blogs
Browse all PLOS Blogs

This Week in PLoS Medicine: HAART treatment adherence; HIV treatment in Ukraine

Michael Morris General

Image Credit: Okko Pyykkö

Two new articles were published this week in PLoS Medicine, both research articles on studies surrounding antiretroviral therapy.

Michael Chung and colleagues show that intensive early adherence counseling at HAART initiation resulted in sustained, significant impact on adherence and virologic treatment failure, whereas use of an alarm device had no effect.

A study by Sabina Alistar and colleagues evaluated the effectiveness and cost effectiveness of different levels of investment in methadone, antiretroviral therapy, or both, in the mixed HIV epidemic in Ukraine.

Remember you can comment on, annotate and rate any PLoS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.

Back to top